Penn Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-51,858
| Closed | -$757K | – | 246 |
|
|
2020
Q4 | $757K | Sell |
51,858
-212,283
| -80% | -$3.1M | 0.1% | 168 |
|
|
2020
Q3 | $3.76M | Sell |
264,141
-10,545
| -4% | -$150K | 0.48% | 91 |
|
|
2020
Q2 | $4.05M | Buy |
+274,686
| New | +$4.05M | 0.53% | 78 |
|
|
2020
Q1 | – | Sell |
-977,526
| Closed | -$4.7M | – | 237 |
|
|
2019
Q4 | $4.7M | Buy |
977,526
+336,979
| +53% | +$1.62M | 0.49% | 74 |
|
|
2019
Q3 | $3.88M | Buy |
640,547
+2,598
| +0.4% | +$15.7K | 0.4% | 95 |
|
|
2019
Q2 | $4.14M | Sell |
637,949
-33,654
| -5% | -$218K | 0.41% | 90 |
|
|
2019
Q1 | $4.76M | Sell |
671,603
-129,153
| -16% | -$916K | 0.46% | 78 |
|
|
2018
Q4 | $3.89M | Buy |
800,756
+345,692
| +76% | +$1.68M | 0.39% | 84 |
|
|
2018
Q3 | $3.35M | Sell |
455,064
-13
| -0% | -$96 | 0.25% | 116 |
|
|
2018
Q2 | $2.9M | Buy |
455,077
+33,644
| +8% | +$215K | 0.22% | 128 |
|
|
2018
Q1 | $2.29M | Sell |
421,433
-122,282
| -22% | -$665K | 0.18% | 148 |
|
|
2017
Q4 | $2.27M | Buy |
543,715
+196,150
| +56% | +$818K | 0.16% | 159 |
|
|
2017
Q3 | $3.35M | Buy |
+347,565
| New | +$3.35M | 0.24% | 122 |
|